Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Notices - 2011 > Application for Permit To Export Controlled Substances/Export Controlled Substances for Re-Export--DEA Forms 161 and 161r

Notices - 2011

[Federal Register Volume 76, Number 44 (Monday, March 7, 2011)]
[Notices]
[Pages 12371-12372]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5052]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number OMB No. 1117-0004]

Agency Information Collection Activities: Proposed Collection; Comments Requested: Application for Permit To Export Controlled Substances/Export Controlled Substances for Re-Export--DEA Forms 161 and 161r

ACTION: 60-Day Notice of Information Collection Under Review.


The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until May 6, 2011. This process is conducted in accordance with 5 CFR 1320.10.

If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Cathy A. Gallagher, Acting Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152; 202-307- 7297.

Written comments concerning this information collection should be sent to the Office of Information and Regulatory Affairs, Office of Management and Budget, Attn: DOJ Desk Officer. The best way to ensure your comments are received is to e-mail them to oira_submission@omb.eop.gov or fax them to 202-395-7285. All comments should reference the 8 digit OMB number for the collection or the title of the collection. If you have questions concerning the collection, please call Cathy A. Gallagher at 202-307-7297 or the DOJ Desk Officer at 202- 395-3176.

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points:

  • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
  • Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
  • Enhance the quality, utility, and clarity of the information to be collected; and
  • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses.

Overview of Information Collection 1117-0004

(1) Type of Information Collection: Extension of a currently approved collection.

(2) Title of the Form/Collection: Application for Permit to Export Controlled Substances/Export Controlled Substances for Reexport--DEA Forms 161 and 161r.

(3) Agency form number, if any, and the applicable component of the Department sponsoring the collection:

Form number: DEA Forms 161 and 161r.

Component: Office of Diversion Control, Drug Enforcement Administration, Department of Justice.

(4) Affected public who will be asked or required to respond, as well as a brief abstract:

Primary: Business or other for-profit.

Other: None.

Abstract: Title 21 CFR 1312.21 and 1312.22 require persons who export controlled substances in Schedules I and II and who reexport controlled substances in Schedules I and II and narcotic controlled substances in Schedules III and IV to obtain a permit from DEA. Information is used to issue export permits, exercise control over exportation of controlled substances, and compile data for submission to the United Nations to comply with treaty requirements.

(5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to

[[Page 12372]]

respond: It is estimated that 69 respondents will respond with Form 161, and 12 respondents will respond with Form 161r, with submissions as follows:

  Number of annual responses Average time per response Burden hours
DEA Form 161 (exportation only) 5,577 30 minutes (0.5 hours) 2,788.5
DEA Form 161r (reexportation) 196 45 minutes (0.75 hours) 147
Certification of exportation from United States to first country 196 15 minutes (0.25 hours) 49
Certification of re-exportation from first country to second country* 235.2 15 minutes (0.25 hours) 58.8
Total     3,043.3

*Assumes three separate re-exports to second countries.

(6) An estimate of the total public burden (in hours) associated with the collection:

3,043.3 annual burden hours.

If additional information is required contact: Lynn Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street, NE., Suite 2E-502, Washington, DC 20530.

Dated: March 1, 2011.

Lynn Murray,
Department Clearance Officer, Department of Justice.

[FR Doc. 2011-5052 Filed 3-4-11; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility